| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Gastroenterology Section, Department of Medicine, The University of Chicago, Chicago, Illinois 60637
Address all correspondence and requests for reprints to: T. A. Brasitus, Gastroenterology Section, Department of Medicine, The University of Chicago, MC4076, 5841 South Maryland Avenue, Chicago Illinois 60637. E-mail: tbrasitu{at}medicine.bsd.uchicago.edu
Previous studies by our laboratory have shown that a noncalcemic
fluorinated analog of 1
,25-dihydroxyvitamin D3,
1
,25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholcalciferol
(F6-D3), significantly reduced the frequency of
colonic adenomas and completely abolished the development of colonic
adenocarcinomas in rats treated with azoxymethane. The mechanisms
involved in this analogs chemopreventive actions, however, remain
unclear. In the present study, we now show that although both
1
,25-dihydroxyvitamin D3 and
F6-D3 inhibited the proliferation of CaCo-2
cells, a human colonic adenocarcinoma cell line, by increasing their
doubling times, only F6-D3 caused an arrest of
these cells in the G1 phase of their cell cycle. This arrest was
accompanied by an increase in the expression of the cyclin-dependent
kinase (cdk) inhibitor proteins, p21Waf1 and
p27Kip1, which served to decrease the activity of
cyclin-dependent kinase 2 and cyclin-dependent kinase 6, whereas the
expression and phosphorylation of pRB were unchanged. In contrast to
the increased expression of these cdk inhibitors, the expression of
cyclin E was decreased, which further inhibited the activity of
cyclin-dependent kinase 2. Collectively, the inhibition of these
cyclin-dependent kinases served to arrest the CaCo-2 cells, independent
of changes in pRB. Furthermore, antibody neutralization studies suggest
that transforming growth factor-ß may mediate the coassociations
between cdk2 and p27Kip1 and cyclin E induced by
F6-D3. These data indicate that cell cycle
arrest may, at least in part, underlie the chemopreventive actions of
F6-D3 observed in the azoxymethane model of
colon cancer. Furthermore, if the antiproliferative action observed in
CaCo-2 cells also occurs in human colonic epithelium,
F6-D3 may have chemopreventive potential
against human colon cancer, as well.
This article has been cited by other articles:
![]() |
B. NURNBERG, S. GRABER, B. GARTNER, J. GEISEL, C. PFOHLER, D. SCHADENDORF, W. TILGEN, and J. REICHRATH Reduced Serum 25-Hydroxyvitamin D Levels in Stage IV Melanoma Patients Anticancer Res, September 1, 2009; 29(9): 3669 - 3674. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ng, J. A. Meyerhardt, K. Wu, D. Feskanich, B. W. Hollis, E. L. Giovannucci, and C. S. Fuchs Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer J. Clin. Oncol., June 20, 2008; 26(18): 2984 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Fakih, D. L. Trump, J. R. Muindi, J. D. Black, R. J. Bernardi, P. J. Creaven, J. Schwartz, M. G. Brattain, A. Hutson, R. French, et al. A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors Clin. Cancer Res., February 15, 2007; 13(4): 1216 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Taghizadeh, M. J. Tang, and I. T. Tai Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy Mol. Cancer Ther., January 1, 2007; 6(1): 309 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Martin-Venegas, S. Roig-Perez, R. Ferrer, and J. J. Moreno Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation J. Lipid Res., July 1, 2006; 47(7): 1416 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Jacobs, M. R. Haussler, and M. E. Martinez Vitamin D Activity and Colorectal Neoplasia: A Pathway Approach to Epidemiologic Studies Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2061 - 2063. [Full Text] [PDF] |
||||
![]() |
D. M. Harris and V. L. W. Go Vitamin D and Colon Carcinogenesis J. Nutr., December 1, 2004; 134(12): 3463S - 3471S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lucas, J. Domenico, and E. W. Gelfand Cyclin-Dependent Kinase 6 Inhibits Proliferation of Human Mammary Epithelial Cells Mol. Cancer Res., February 1, 2004; 2(2): 105 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Wali, S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, J. Hart, J. Wang, M. Wen, A. Ramaswamy, L. Joseph, et al. Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1653 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Galbiati, L. Polastri, S. Gregori, M. Freschi, M. Casorati, U. Cavallaro, P. Fiorina, F. Bertuzzi, A. Zerbi, G. Pozza, et al. Antitumorigenic and Antiinsulinogenic Effects of Calcitriol on Insulinoma Cells and Solid {beta}-Cell Tumors Endocrinology, October 1, 2002; 143(10): 4018 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chen, B. H. Davis, M. D. Sitrin, T. A. Brasitus, and M. Bissonnette Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3 Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G864 - G874. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |